ARCHIVES

NCI Test Panels Available For Marker Evaluation

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000